Personalised Healthcare Roche is a global leader in personalised healthcare by uniting pharmaceuticals and diagnostics under one roof. This enables integrated data strategies, real-world evidence, and companion diagnostics that tailor therapies. Sales impact: offer AI-driven analytics platforms, data integration across R&D, manufacturing, and care delivery, cloud-based data warehouses, and services to accelerate development, regulatory submissions, and market access.

Diagnostics Leadership As the world leader in in vitro diagnostics and tissue-based cancer diagnostics, Roche relies on advanced lab workflows and data accuracy. Opportunities exist for LIMS and instrument interoperability, cloud analytics, workflow automation, and regulatory compliant software that improves test accuracy and turnaround. Propose end-to-end digital lab solutions, data integration with ERP, and managed services to optimize diagnostic throughput.

Global Scale With a large global workforce and headquarters in Basel, Roche represents a sizable enterprise with multi-region procurement and deployment needs. This creates demand for scalable ERP/CRM integrations, cybersecurity, cloud migrations, and enterprise managed services, delivered with robust governance and training to support global rollouts and regulatory compliance.

Sustainability Access Roche’s sustained sustainability leadership and focus on patient access enable opportunities in ESG data reporting, supply chain transparency, and payer-level analytics. Propose solutions that measure social impact, environmental footprint, and access outcomes, integrate with existing sustainability platforms, and support collaborations with health systems and governments to expand coverage.

Converged Health The convergence of pharmaceuticals and diagnostics at Roche opens pathways for co-development of digital health solutions, companion diagnostics, and remote patient monitoring. Opportunities include interoperability platforms across R&D, manufacturing, and care delivery; data-driven clinical trial support; and strategic partnerships to accelerate commercialization of precision therapies.